Similarly, Hsieh et al. found that in esophageal squamous cell carcinoma (ESCC), reduced expression of plasma gelsolin (pGSN) impairs its ability to compete with oncogenic TNC for binding to integrin αvβ3. The gene discussed is GSN; the disease is esophageal squamous cell carcinoma.